1. |
Porter KR, McCarthy BJ, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro-oncology, 2010, 12(6):520-527.
|
2. |
Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS Statistical Report:primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-oncology, 2013, 15(5):646-647.
|
3. |
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med, 2008, 359(5):492-507.
|
4. |
Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase Ⅲ study:5-year analysis of the EORTC-NCIC trial. Lancet Oncol, 2009, 10(5):459-466.
|
5. |
Chamberlain MC. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas. Cancer, 2010, 116(17):3988-3999.
|
6. |
Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol, 2009, 62(10):1013-1020.
|
7. |
Shea SJ, Bouter LM, Peterson J, et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS ONE, 2007, 2(12):e1350.
|
8. |
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses:The PRISMA statement International. J Surg, 2010, 8(5):336-341.
|
9. |
《中国循证医学杂志》稿约.中国循证医学杂志, 2011, 11(1):110-112.
|
10. |
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR:a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7:10.
|
11. |
孙家忠, 孙妍蕾, 杨梅, 等.替莫唑胺胶囊治疗脑胶质瘤的有效性和安全性系统评价.中国医院用药评价与分析, 2012, 12(7):578-581.
|
12. |
Zhang G, Huang S, Wang Z. A meta-analysis of bevacizumab alone and in combination with irinotecan in the treatment of patients with recurrent glioblastoma multiforme. J Clin Neurosci, 2012, 19(12):1636-1640.
|
13. |
Koukourakis GV. Has bevacizumab (Avastin) given extra therapeutic gain in metastatic colorectal cancer and malignant brain gliomas? Systematic review answering this question. Recent Pat Inflamm Allergy Drug Discov, 2012, 6(1):70-77.
|
14. |
Ford E, Catt S, Chalmers A, et al. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol, 2012, 14(4):392-404.
|
15. |
de Witt HPC, Robles SG, Zwinderman AH, et al. Impact of intraoperative stimulation brain mapping on glioma surgery outcome:A meta-analysis. J Clin Oncol, 2012, 30(20):2559-2565.
|
16. |
Chen C, Xu T, Lu Y, et al. The efficacy of temozolomide for recurrent glioblastoma multiforme. Eur J Neurol, 2013, 20(2):223-230.
|
17. |
Binello E, Green S, Germano IM. Radiosurgery for high-grade glioma. Surg Neurol Int, 2012, 3(Suppl 2):S118-126.
|
18. |
Wong JM, Panchmatia JR, Ziewacz JE, et al. Patterns in neurosurgical adverse events:intracranial neoplasm surgery. Neurosurg Focus, 2012, 33(5):E16.
|
19. |
Hart MG, Grant R, Garside R, et al. Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev, 2011, (3):CD007294.
|
20. |
Pannullo SC, Fraser JF, Moliterno J, et al. Stereotactic radiosurgery:A meta-analysis of current therapeutic applications in neuro-oncologic disease. J Neurooncol, 2011, 103(1):1-17.
|
21. |
Madsen K, Poulsen HS. Needs for everyday life support for brain tumour patients' relatives:systematic literature review. Eur J Cancer Care (Engl), 2011, 20(1):33-43.
|
22. |
Kerrigan S, Grant R. Antiepileptic drugs for treating seizures in adults with brain tumours. Cochrane Database Syst Rev, 2011, (8):CD008586.
|
23. |
Lashkari HP, Saso S, Moreno L, et al. Using different schedules of Temozolomide to treat low grade gliomas:Systematic review of their efficacy and toxicity. J Neurooncol, 2011, 105(2):135-147.
|
24. |
Kubben PL, ter Meulen KJ, Schijns OE, et al. Intraoperative MRI-guided resection of glioblastoma multiforme:a systematic review. Lancet Oncol, 2011, 12(11):1062-1070.
|
25. |
Dixit S, Hingorani M, Achawal S, et al. The sequential use of carmustine wafers and post-operative radiotherapy with concomitanttemozolomide followed by adjuvant temozolomide:a clinical review. Br J Neurosurg, 2011, 25(4):459-469.
|
26. |
Wong ET, Gautam S, Malchow C, et al. Bevacizumab for recurrent glioblastoma multiforme:A meta-analysis. JNCCN, 2011, 9(4):403-407.
|
27. |
Aydin B, Patil M, Bekele N, et al. Vincristine in high-grade glioma. Anticancer Research, 2010, 30(6):2303-2310.
|
28. |
Xu T, Chen J, Lu Y, et al. Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma:a systematic review and survival-gain analysis. BMC Cancer, 2010, 10:252.
|
29. |
de Witt Hamer PC. Small molecule kinase inhibitors in glioblastoma:a systematic review of clinical studies. Neuro Oncol, 2010, 12(3):304-316.
|
30. |
梁惠, 董士丽.国内恶性脑胶质瘤术后放疗联合替莫唑胺化疗疗效与安全性的Meta分析.现代肿瘤医学, 2010, 18(12):2345-2348.
|
31. |
Amelio D, Lorentini S, Schwarz M, et al. Intensity-modulated radiation therapy in newly diagnosed glioblastoma:A systematic review on clinical and technical issues. Radiother Oncol, 2010, 97(3):361-369.
|
32. |
Maucort-Boulch D, Baron MH, Pommier P, et al. Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials. Cancer Radiother, 2010, 14(1):34-41.
|
33. |
Moreno L, Bautista F, Ashley S, et al. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Eur J Cancer, 2010, 46(12):2253-2259.
|
34. |
Tsitlakidis A, Foroglou N, Venetis CA, et al. Biopsy versus resection in the management of malignant gliomas:a systematic review and meta-analysis. J Neurosurg, 2010, 112(5):1020-1032.
|
35. |
毕唯静, 王铭, 李平.高级别胶质瘤动脉灌注化疗的系统评价.实用肿瘤杂志, 2010, 25(3):277-283.
|
36. |
Tapia-Perez JH, Sanchez-Aguilar M, Schneider T. The role of statins in neurosurgery. Neurosurg Rev, 2010, 33(3):259-270.
|
37. |
Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients:a systematic review of observational studies. J Natl Cancer Inst, 2011, 103(1):61-76.
|
38. |
王小虎, 郭丽云, 马彬, 等.放疗联合替莫唑胺治疗多形性成胶质细胞瘤的meta分析.肿瘤, 2010, 30(12):1056-1064.
|
39. |
李橙橙, 杨永健, 田金徽, 等.术后辅助化疗治疗成人脑恶性胶质瘤系统评价.药物流行病学杂志, 2009, 18(4):236-241.
|
40. |
Hart MG, Grant R, Garside R, et al. Temozolomide for high grade glioma. Cochrane Database Syst Rev, 2008, (4):CD007415.
|
41. |
Quon H, Abdulkarim B. Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas. Cochrane Database Syst Rev, 2008, (2):CD007104.
|
42. |
Buie LW, Valgus J. Bevacizumab:a treatment option for recurrent glioblastoma multiforme. Ann Pharmacother, 2008, 42(10):1486-1490.
|
43. |
Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery, 2008, 62(4):753-764.
|
44. |
Sabel M, Giese A. Safety profile of carmustine wafers in malignant glioma:a review of controlled trials and a decade of clinical experience. Curr Med Res Opin, 2008, 24(11):3239-3257.
|
45. |
Keith BD. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer, 2008, 8:84.
|
46. |
Hart MG, Grant R, Garside R, et al. Chemotherapeutic wafers for high grade glioma. Cochrane Database Syst Rev, 2008, (3):CD007294.
|
47. |
Garside R, Pitt M, Anderson R, et al. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma:A systematic review and economic evaluation. Health Technol Assess, 2007, 11(45):1-221.
|
48. |
Perry J, Chambers A, Spithoff K, et al. Gliadel wafers in the treatment of malignant glioma:a systematic review. Curr Oncol, 2007, 14(5):189-194.
|
49. |
Perry J, Laperriere N, Zuraw L, et al. Adjuvant chemotherapy for adults with malignant glioma:A systematic review. Can J Neurol Sci, 2007, 34(4):402-410.
|
50. |
Spiegel BMR, Esrailian E, Laine L, et al. Clinical impact of adjuvant chemotherapy in glioblastoma multiforme a meta-analysis. CNS Drugs, 2007, 21(9):775-787.
|
51. |
Tsao MN, Mehta MP, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys, 2005, 63(1):47-55.
|
52. |
Berg G, Blomquist E, Cavallin-Stahl E. A systematic overview of radiation therapy effects in brain tumours. Acta Oncologica, 2003, 42(5-6):582-588.
|
53. |
Davies E, Higginson IJ. Communication, information and support for adults with malignant cerebral glioma:a systematic literature review. Support Care Cancer, 2003, 11(1):21-29.
|
54. |
Dinnes J, Cave C, Huang S, et al. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer, 2002, 86(4):501-505.
|
55. |
Stewart LA. Chemotherapy in adult high-grade glioma:A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet, 2002, 359(9311):1011-1018.
|
56. |
Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults:A systematic review. Radiother Oncol, 2002, 64(3):259-273.
|
57. |
Glioma Meta-Analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma. Cochrane Database Syst Rev, 2002, (4):CD003913.
|
58. |
Metcalfe SE, Grant R. Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev, 2001, (3):CD002034.
|
59. |
Dinnes J, Cave C, Huang S, et al. The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma:a rapid and systematic review. Health Technol Assess, 2001, 5(13):1-73.
|
60. |
Huncharek M, Wheeler L, McGarry R, et al. Chemotherapy response rates in recurrent/progressive pediatric glioma; Results of a systematic review. Anticancer Res, 1999, 19(4C):3569-3574.
|
61. |
Fine HA, Dear KBG, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer, 1993, 71(8):2585-2597.
|
62. |
屈会起, 张金钟, 邱明才.循证医学的系统评价方法.中华医院管理杂志, 2000, 16(6):335-336.
|
63. |
Jakola AS, Unsgård G, Myrmel KS, et al. Surgical strategy in grade Ⅱ astrocytoma:a population-based analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting. Acta Neurochir (Wien), 2013, 155(12):2227-2235.
|
64. |
卫茂玲. Cochrane系统评价在中国的现状与问题.中国循证医学杂志, 2006, 6(2):150-151.
|
65. |
张俊华, 商洪才, 张伯礼.系统评价/Meta分析质量的评价方法.中西医结合学报, 2008, 6(4):337-340.
|
66. |
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available at: http://www.cochrane-handbook.org.
|